-
[1] Forastiere A.A., Metch B., Schuller D.E., Ensley J.F., Hutchins L.F., Triozzi P., et al., Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol, 1992, 10, 1245–1251
-
RELATION NAME
-
[3] Clavel M., Vermorken J.B., Cognetti F., Cappelaere P., de Mulder P.H., Schornagel J.H., et al., Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group. Ann Oncol, 1994, 5, 521–526
-
RELATION NAME
-
RELATION NAME
-
[6] Grazi G.L., Cescon M., Pierangeli F., Ercolani G., Gardini A., Cavallarii A., et al., Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology, 2000, 47, 481–486
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME